Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy

被引：0
|
作者：
Riccardo Giampieri
Elena Maccaroni
Alessandra Mandolesi
Michela Del Prete
Kalliopi Andrikou
Luca Faloppi
Alessandro Bittoni
Maristella Bianconi
Marina Scarpelli
Raffaella Bracci
Mario Scartozzi
Stefano Cascinu
机构：
[1] Azienda Ospedaliero Universitaria Ospedali Riuniti,Department of Medical Oncology
[2] Università Politecnica delle Marche,Department of Pathology
[3] Università Politecnica delle Marche,Department of Medical Oncology
[4] Università di Cagliari,undefined
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Gastric cancer; Mismatch repair; Microsatellite instability; Chemotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：156 / 163
页数：7
相关论文
共 50 条
  • [1] Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy
    Giampieri, Riccardo
    Maccaroni, Elena
    Mandolesi, Alessandra
    Del Prete, Michela
    Andrikou, Kalliopi
    Faloppi, Luca
    Bittoni, Alessandro
    Bianconi, Maristella
    Scarpelli, Marina
    Bracci, Raffaella
    Scartozzi, Mario
    Cascinu, Stefano
    GASTRIC CANCER, 2017, 20 (01) : 156 - 163
  • [2] Mismatch repair deficiency is associated with a better response and a longer survival time in patients with metastatic colorectal cancer receiving first-line chemotherapy
    Brueckl, WM
    Wein, A
    Moesch, C
    Schaber, S
    Jung, A
    Brabletz, T
    Boxberger, F
    Guenther, K
    Wiest, GH
    Kirchner, T
    Hohenberger, W
    Hahn, EG
    GASTROENTEROLOGY, 2001, 120 (05) : A258 - A258
  • [3] Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer
    Oh, Chung Ryul
    Kim, Eo Jin
    Chae, Heejung
    Park, Young Soo
    Ryu, Min-Hee
    Kim, Hyung-Don
    Kang, Yoon-Koo
    GASTRIC CANCER, 2024, 27 (04) : 811 - 818
  • [4] Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum chemotherapy for metastatic, recurrent, or locally advanced unresectable gastric cancer.
    Oh, Chung Ryul
    Kim, Eo Jin
    Chae, Heejung
    Park, Young Soo
    Ryu, Min-Hee
    Kim, Hyung-Don
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 461 - 461
  • [5] Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting
    Saberzadeh-Ardestani, Bahar
    Jones, Jeremy C.
    McWilliams, Robert R.
    Tougeron, David
    Halfdanarson, Thorvardur R.
    Guimbaud, Rosine
    Hubbard, Joleen M.
    Flecchia, Clemence
    Shi, Qian
    Alouani, Emily
    Sonbol, Mohamad B.
    Ticku, Jonathan
    Jin, Zhaohui
    Taieb, Julien
    Sinicrope, Frank A.
    EUROPEAN JOURNAL OF CANCER, 2024, 196
  • [6] Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer
    Cazeneuve, Nicolas
    Bouche, Olivier
    Leger, Julie
    Borg, Christophe
    Labbe-Devilliers, Catherine
    Lucidarme, Olivier
    Tasu, Jean-Pierre
    Manfredi, Sylvain
    Aube, Christophe
    Trillaud, Herve
    Manzoni, Philippe
    Marcus, Claude
    Terrebonne, Eric
    Douillard, Jean -Yves
    Chautard, Romain
    Lobet, Sarah
    Bleuzen, Aurore
    Lecomte, Thierry
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (07)
  • [7] Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
    Ardestani, Bahar Saberzadeh
    Jones, Jeremy Clifton
    Mcwilliams, Robert R.
    Tougeron, David
    Halfdanarson, Thorvardur Ragnar
    Guimbaud, Rosine
    Hubbard, Joleen M.
    Flecchia, Clemence
    Shi, Qian
    Alouani, Emily Linda
    Sonbol, Bassam Bassam
    Ticku, Jonathan
    Jin, Zhaohui
    Taieb, Julien
    Sinicrope, Frank A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 55 - 55
  • [8] Primary tumor histology and location as predictive factors for clinical outcome in metastatic gastric cancer (GC) patients receiving first-line chemotherapy
    Bittoni, Alessandro
    Scartozzi, Mario
    Giampieri, Riccardo
    Faloppi, Luca
    Bianconi, Maristella
    Mandolesi, Alessandra
    Del Prete, Michela
    Pistelli, Mirco
    Cecchini, Luca
    Bearzi, Italo
    Cascinu, Stefano
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
    Jun-Eul Hwang
    Ha-Na Kim
    Dae-Eun Kim
    Hyun-Jung Choi
    Sung-Hoon Jung
    Hyun-Jeong Shim
    Woo-Kyun Bae
    Eu-Chang Hwang
    Sang-Hee Cho
    Ik-Joo Chung
    BMC Cancer, 11
  • [10] Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
    Hwang, Jun-Eul
    Kim, Ha-Na
    Kim, Dae-Eun
    Choi, Hyun-Jung
    Jung, Sung-Hoon
    Shim, Hyun-Jeong
    Bae, Woo-Kyun
    Hwang, Eu-Chang
    Cho, Sang-Hee
    Chung, Ik-Joo
    BMC CANCER, 2011, 11
12345